tiprankstipranks

2seventy Bio lowers net cash spend range to $40M-60M for FY24

2seventy Bio lowers net cash spend range to $40M-60M for FY24

The Company has lowered its net cash spend range to $40-60 million for 2024. Cash, cash equivalents, and marketable securities totaled $201.9 million as of June 30, 2024; the Company continues to expect to have cash runway beyond 2027.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue